Novonesis AS 

€51.50
208
+€1.50+3% Today

Statistics

Day High
51.5
Day Low
51.5
52W High
64.5
52W Low
46.4
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1.76%
Dividend
0.91

Upcoming

Dividends

1.76%Dividend Yield
Apr 26
€0.58
Sep 25
€0.30
Apr 25
€0.56
Sep 24
€0.27
May 24
€0.27
10Y Growth
6.65%
5Y Growth
4.59%
3Y Growth
-13.46%
1Y Growth
2%

Earnings

20AugExpected
Q1 2026
Next
0.57
0.61
0.65
0.69
Expected EPS
0.6578878209460199
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NZM.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap148.41B
Pfizer is a global pharmaceutical company that competes with Novonesis AS in the development and marketing of medications and vaccines for various diseases, including those in areas where Novonesis may operate.
Merck
MRK
Mkt Cap298.33B
Merck & Co., Inc. is a leading healthcare company that develops innovative pharmaceuticals and vaccines, directly competing with Novonesis AS in several therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap560.33B
Johnson & Johnson is a diversified healthcare giant that competes with Novonesis AS through its pharmaceutical division, developing drugs that may overlap with Novonesis' product portfolio.
GSK
GSK
Mkt Cap103.31B
GlaxoSmithKline is a global healthcare company that competes with Novonesis AS in the pharmaceutical and healthcare market, particularly in the development of vaccines and medications.
Novartis
NVS
Mkt Cap284.61B
Novartis is a multinational pharmaceutical company that competes with Novonesis AS in researching, developing, manufacturing, and marketing a wide range of healthcare products.
Abbvie
ABBV
Mkt Cap401.47B
AbbVie is a biopharmaceutical company that competes with Novonesis AS in the discovery, development, and commercialization of new medicines and therapies.
Bristol-Myers Squibb
BMY
Mkt Cap116.95B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Novonesis AS in the development of prescription pharmaceuticals in several therapeutic areas.
Roche
RHHBY
Mkt Cap331.58B
Roche Holding AG is a healthcare company that competes with Novonesis AS in the pharmaceutical and diagnostics industries, focusing on oncology, immunology, and infectious diseases.
Sanofi
SNY
Mkt Cap107.77B
Sanofi is a global healthcare leader that competes with Novonesis AS in the development and marketing of therapeutic solutions in areas such as rare diseases, multiple sclerosis, and oncology.
Astrazeneca
AZN
Mkt Cap288.38B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Novonesis AS in the discovery, development, and commercialization of prescription medicines, particularly in the oncology sector.

About

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.
Show more...
CEO
ISIN
US6701081092

Listings

0 Comments

Share your thoughts

FAQ

What is Novonesis AS stock price today?
The current price of NZM.MU is €51.50 EUR — it has increased by +3% in the past 24 hours. Watch Novonesis AS stock price performance more closely on the chart.
What is Novonesis AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Novonesis AS stocks are traded under the ticker NZM.MU.
Is Novonesis AS stock price growing?
NZM.MU stock has risen by +3% compared to the previous week, the month change is a +3% rise, over the last year Novonesis AS has showed a -19.53% decrease.
When is the next Novonesis AS earnings date?
Novonesis AS is going to release the next earnings report on August 20, 2026.
What were Novonesis AS earnings last quarter?
NZM.MU earnings for the last quarter are 0.57 EUR per share, whereas the estimation was 0.69 EUR resulting in a -17.94% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Novonesis AS pay dividends?
Yes, NZM.MU dividends are paid semi-annual. The last dividend per share was 0.58 EUR. As of today, Dividend Yield (FWD)% is 1.76%.
In which sector is Novonesis AS located?
Novonesis AS operates in the Other sector.
When did Novonesis AS complete a stock split?
Novonesis AS has not had any recent stock splits.